... acetylcholine esterase, superior in activity to TACRINE, the first drug licensed in the USA for Alzheimer’s disease and E2020 which ... was licensed recently by Eisai Pharmaceuticals. In addition, Huperzine A has ... acid glutamate.Huperzine A has been proven superior to drugs licensed for the treatment of Alzheimer’s, including the leading anticholinesterase ...